Biphasic effects of zonisamide on serotonergic system in rat hippocampus

被引:78
作者
Okada, M [1 ]
Hirano, T
Kawata, Y
Murakami, T
Wada, K
Mizuno, K
Kondo, T
Kaneko, S
机构
[1] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan
[2] Natl Hosp, Dept Biochem Res, Hanamaki 025, Japan
关键词
epilepsy; microdialysis; serotonin release; serotonin metabolism; zonisamide;
D O I
10.1016/S0920-1211(98)00109-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To study the mechanisms of antiepileptic action of zonisamide (ZNS), we determined the effects of ZNS on extracellular, total levels and re-uptake activity of serotonin (5-KT) in rat striatum and hippocampus. After acute administrations, plasma ZNS concentrations associated with anticonvulsive action (effective concentrations) increased the total levels of 5-HT, its metabolise (5-hydroxyindoleacetic acid: 5-HIAA) and precursor (5-hydroxytryptophan: 5-HTP). After chronic administration of ZNS, effective plasma concentrations also increased the extracellular and total levels of 5-MT, 5-HIAA, and 5-HTP. On the other hand, after both acute and chronic administrations of ZNS, a supra-effective ZNS concentration either decreased or did not affect the total levels of these substances. Therefore, the stimulatory effects of ZNS on the 5-HT system were reduced by an increase in ZNS concentration to supra-effective concentrations. ZNS concentrations of 30-1000 mu M did not affect hippocampal 5HT re uptake activity in vitro. These results suggest that ZNS has biphasic effects on the 5-HT system, in that effective concentrations of ZNS enhance and supra-effective concentrations of ZNS reduce the function of the 5-HT system. These biphasic effects of ZNS on the 5-HT system may be involved in the mechanisms of action of the antiepileptic and psychotropic effects, and side effects of ZNS. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:187 / 197
页数:11
相关论文
共 45 条
[11]   DIFFERENT EFFECTS OF L-TYPE, N-TYPE AND T-TYPE CALCIUM-CHANNEL BLOCKERS ON STRIATAL DOPAMINE RELEASE MEASURED BY MICRODIALYSIS IN FREELY MOVING RATS [J].
KATO, T ;
OTSU, Y ;
FURUNE, Y ;
YAMAMOTO, T .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (01) :99-107
[12]  
Kito M, 1994, Seizure, V3, P141, DOI 10.1016/S1059-1311(05)80205-5
[13]   Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy [J].
Kondo, T ;
Kaneko, S ;
Amano, Y ;
Egawa, I .
EPILEPSIA, 1996, 37 (12) :1242-1244
[14]  
KUBOTA S, 1982, HIROSAKI MED J, V34, P660
[15]   DEAMINATION OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN BY TYPE-A MONOAMINE-OXIDASE IN DISCRETE REGIONS OF THE RAT-BRAIN AND INHIBITION BY RS-8359 [J].
KUMAGAE, Y ;
MATSUI, Y ;
IWATA, N .
JAPANESE JOURNAL OF PHARMACOLOGY, 1991, 55 (01) :121-128
[16]   FLUOXETINE, A SELECTIVE SEROTONIN-UPTAKE INHIBITOR, ENHANCES THE ANTICONVULSANT EFFECTS OF PHENYTOIN, CARBAMAZEPINE, AND AMELTOLIDE (LY201116) [J].
LEANDER, JD .
EPILEPSIA, 1992, 33 (03) :573-576
[17]  
MASUDA Y, 1980, ARZNEIMITTEL-FORSCH, V30-1, P477
[18]   RELATIONSHIPS BETWEEN PLASMA-CONCENTRATIONS OF DIPHENYLHYDANTOIN, PHENOBARBITAL, CARBAMAZEPINE, AND "3-SULFAMOYLMETHYL-1,2-BENZISOXAZOLE (AD-810) - NEW ANTICONVULSANT AGENT, AND THEIR ANTICONVULSANT OR NEUROTOXIC EFFECTS IN EXPERIMENTAL-ANIMALS [J].
MASUDA, Y ;
UTSUI, Y ;
SHIRAISHI, Y ;
KARASAWA, T ;
YOSHIDA, K ;
SHIMIZU, M .
EPILEPSIA, 1979, 20 (06) :623-633
[19]  
MATSUMOTO K, 1983, ARZNEIMITTEL-FORSCH, V33-2, P961
[20]  
MIMAKI T, 1988, JPN J PSYCHIAT NEUR, V42, P640